• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

商业菌株衍生的临床酿酒酵母可以在不增加致病性的情况下进化出新的表型。

Commercial strain-derived clinical Saccharomyces cerevisiae can evolve new phenotypes without higher pathogenicity.

机构信息

Department of Biotechnology and Microbiology, University of Debrecen, Debrecen, Hungary.

Postdoctoral Fellowship Programme of the Hungarian Academy of Sciences (MTA), Budapest, Hungary.

出版信息

Mol Nutr Food Res. 2017 Nov;61(11). doi: 10.1002/mnfr.201601099. Epub 2017 Aug 29.

DOI:10.1002/mnfr.201601099
PMID:28731263
Abstract

SCOPE

Saccharomyces cerevisiae is one of the most important microbes in food industry, but there is growing evidence on its potential pathogenicity as well. Its status as a member of human mycobiome is still not fully understood.

METHODS AND RESULTS

In this study, we characterize clinical S. cerevisiae isolates from Hungarian hospitals along with commercial baking and probiotic strains, and determine their phenotypic parameters, virulence factors, interactions with human macrophages, and pathogenicity. Four of the clinical isolates could be traced back to commercial strains based on genetic fingerprinting. Our observations indicate that the commercial-derived clinical isolates have evolved new phenotypes and show similar, or in two cases, significantly decreased pathogenicity. Furthermore, immunological experiments revealed that the variability in human primary macrophage activation after coincubation with yeasts is largely donor and not isolate dependent.

CONCLUSION

Isolates in this study offer an interesting insight into the potential microevolution of probiotic and food strains in human hosts. These commensal yeasts display various changes in their phenotypes, indicating that the colonization of the host does not necessarily impose a selective pressure toward higher virulence/pathogenicity.

摘要

范围

酿酒酵母是食品工业中最重要的微生物之一,但越来越多的证据表明其具有潜在的致病性。其作为人类真菌组的一部分的地位尚未完全被理解。

方法和结果

在这项研究中,我们对来自匈牙利医院的临床酿酒酵母分离株以及商业烘焙和益生菌菌株进行了表征,并确定了它们的表型参数、毒力因子、与人类巨噬细胞的相互作用以及致病性。根据遗传指纹图谱,其中四个临床分离株可以追溯到商业菌株。我们的观察表明,商业衍生的临床分离株已经进化出了新的表型,并且表现出相似的,或者在两种情况下,显著降低的致病性。此外,免疫学实验表明,在与酵母共同孵育后,人类原代巨噬细胞激活的变异性在很大程度上取决于供体而不是分离株。

结论

本研究中的分离株为益生菌和食品菌株在人类宿主中的潜在微进化提供了一个有趣的视角。这些共生酵母在其表型上显示出各种变化,表明宿主的定植不一定会对更高的毒力/致病性施加选择压力。

相似文献

1
Commercial strain-derived clinical Saccharomyces cerevisiae can evolve new phenotypes without higher pathogenicity.商业菌株衍生的临床酿酒酵母可以在不增加致病性的情况下进化出新的表型。
Mol Nutr Food Res. 2017 Nov;61(11). doi: 10.1002/mnfr.201601099. Epub 2017 Aug 29.
2
A comparison of clinical and food Saccharomyces cerevisiae isolates on the basis of potential virulence factors.基于潜在毒力因子对临床和食品来源的酿酒酵母分离株进行比较。
Antonie Van Leeuwenhoek. 2006 Oct;90(3):221-31. doi: 10.1007/s10482-006-9077-7. Epub 2006 Jul 27.
3
Genome-Wide Screen for Genes Contributing to Opportunistic Pathogenicity in an Invertebrate Model Host.在无脊椎动物模型宿主中对导致机会致病性的基因进行全基因组筛选。
G3 (Bethesda). 2018 Jan 4;8(1):63-78. doi: 10.1534/g3.117.300245.
4
Characterization of Cell Wall Proteins in Saccharomyces cerevisiae Clinical Isolates Elucidates Hsp150p in Virulence.酿酒酵母临床分离株细胞壁蛋白的表征揭示了Hsp150p在毒力中的作用。
PLoS One. 2015 Aug 13;10(8):e0135174. doi: 10.1371/journal.pone.0135174. eCollection 2015.
5
Review of current methods for characterizing virulence and pathogenicity potential of industrial Saccharomyces cerevisiae strains towards humans.工业酿酒酵母菌株对人类的毒力和致病潜力表征的当前方法综述。
FEMS Yeast Res. 2015 Sep;15(6). doi: 10.1093/femsyr/fov057. Epub 2015 Jul 19.
6
Differences in activation of MAP kinases and variability in the polyglutamine tract of Slt2 in clinical and non-clinical isolates of Saccharomyces cerevisiae.酿酒酵母临床和非临床分离株中 MAP 激酶的激活差异和 Slt2 多谷氨酰胺区的变异性。
Yeast. 2010 Aug;27(8):549-61. doi: 10.1002/yea.1799.
7
In vivo virulence of commercial Saccharomyces cerevisiae strains with pathogenicity-associated phenotypical traits.具有致病性表型特征的商业酿酒酵母菌株的体内毒力。
Int J Food Microbiol. 2011 Jan 5;144(3):393-9. doi: 10.1016/j.ijfoodmicro.2010.10.025. Epub 2010 Oct 28.
8
Isolation of Saccharomyces cerevisiae strains from different food matrices and their preliminary selection for a potential use as probiotics.从不同食品基质中分离酿酒酵母菌株,并对其作为潜在益生菌的用途进行初步筛选。
J Appl Microbiol. 2008 Dec;105(6):1919-28. doi: 10.1111/j.1365-2672.2008.03968.x.
9
Epidemiological investigation of vaginal Saccharomyces cerevisiae isolates by a genotypic method.采用基因分型方法对阴道酿酒酵母分离株进行流行病学调查。
J Clin Microbiol. 1998 Feb;36(2):557-62. doi: 10.1128/JCM.36.2.557-562.1998.
10
Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections.来自酿酒酵母属的食物和益生菌菌株可能是人类全身感染的一个源头。
Int J Food Microbiol. 2006 Aug 1;110(3):286-90. doi: 10.1016/j.ijfoodmicro.2006.04.023. Epub 2006 Jun 19.

引用本文的文献

1
Heme Oxygenase-1 () Loss of Function Increases the In-Host Fitness of the Probiotic Yeast in a Mouse Fungemia Model.血红素加氧酶-1()功能丧失增加了益生菌酵母在小鼠真菌血症模型中的宿主体内适应性。
J Fungi (Basel). 2022 May 18;8(5):522. doi: 10.3390/jof8050522.
2
Virulence Factors and in-Host Selection on Phenotypes in Infectious Probiotic Yeast Isolates ().感染性益生菌酵母分离株的毒力因子及宿主内表型选择()
J Fungi (Basel). 2021 Sep 11;7(9):746. doi: 10.3390/jof7090746.
3
Uric acid levels are independent of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease: A reappraisal of the role of S. cerevisiae in this setting.
在克罗恩病中,尿酸水平独立于抗酿酒酵母抗体(ASCA):对酿酒酵母在此情况下作用的重新评估。
Virulence. 2018;9(1):1224-1229. doi: 10.1080/21505594.2018.1496779.